Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
EXAMINE Trial Post-Hoc Analyses of Mortality Data Regarding Cardiovascular Safety of Alogliptin Presented at American Diabetes Association's 76th Scientific Sessions and Published in Diabetes Care
2016-06-12 11:10
ViiV Healthcare Announces FDA Approval to Lower the Weight Limit for dolutegravir in Children and Adolescents Living With HIV
2016-06-10 21:44
ProPak Asia 2016 -- Connecting the World to AEC in Thailand
2016-06-10 15:40
Baricitinib significantly reduces joint damage progression in rheumatoid arthritis in patients who do not respond to conventional DMARDs
2016-06-09 18:45
Patient-reported Outcomes across Phase 3 studies of Baricitinib demonstrate Statistically Significant Improvements in Physical Function and Quality of Life Symptoms in Patients with Rheumatoid Arthritis (RA)
2016-06-09 18:45
Takeda Licenses Global Rights to Theravance Biopharma's TD-8954, a Novel 5-HT4 Agonist and Motility Agent for Gastrointestinal Motility Disorders
2016-06-08 21:02
Disruptive Technologies and Emerging Trends Drive Life Science Transformation
2016-06-07 21:05
Results of Clinical and Patient-Reported Outcomes Data for Baricitinib in Patients with Rheumatoid Arthritis to be Presented at Annual European Congress of Rheumatology (EULAR 2016)
2016-06-07 19:00
Takeda to Present New Data at the American Diabetes Association's 76th Scientific Sessions
2016-06-07 01:09
Finesse SmartFactory(TM) Platform Featured in Alvotech Opening of New Manufacturing and Lab Facility in Iceland
2016-06-06 21:00
SIRveNIB, a Major Primary Liver Cancer Study in the Asia-Pacific Region, Completes Enrolment
2016-06-06 20:54
Daiichi Sankyo to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on Thursday, June 9th, 2016
2016-06-06 20:30
Hutchison China MediTech to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on June 10, 2016
2016-06-06 20:30
Merck Partners with Array BioPharma and Pierre Fabre to Initiate BRAF-mutant CRC Phase III Trial
2016-06-06 08:05
ADI-PEG 20 plus Gemcitabine and nab-Paclitaxel Shows Robust Anti-tumor Activity in Advanced Pancreatic Cancer
2016-06-03 22:00
Aptuit Names Henning Steinhagen as EVP Drug Discovery and Development, and Site-Head Verona
2016-06-01 08:00
Governments on Track to Eliminate Viral Hepatitis by 2030
2016-05-31 09:00
WHO Recommends Rapid Test for Extensively Resistant Tuberculosis
2016-05-30 15:15
NUS Engineering team develops novel technology to "print" customised tablets for personalised medicine
2016-05-26 12:08
PharmaBlock Listed on the New Third Board and Plans to File for the GEM Exchanges at the End of 2016
2016-05-25 09:00
1
240
241
242
243
244
247